Free tool
Stocks near their 52-week high
We cover 31 companies trading within 5% of their own 52-week high. The median market value in the group is $12.57B. Across the group, the median move over the past trading day is +1.52%. 100% of the 30 with a 200-day average trade above it. Price change over the past year runs from +12.0% to +159.1% across the middle 80 percent of the group, with a median of +38.7%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
31 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.